Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial

Robert P. Giugliano, Erin A. Bohula, Andrea Bellavia, Gaetano M. De Ferrari, Lawrence A. Leiter, Jose C. Nicolau, Ajay K. Bhatia, Sabina A. Murphy, Lyrica Liu, Huei Wang, Vladimir Blaha, Andrejs Erglis, Jorge Ferreira, Assen Goudev, Henrik K. Jensen, Robert Gabor Kiss, Gilles Montalescot, Alexandr Parkhomenko, Naveed Sattar, Peter Sinnaeve, Rimvydas Slapikas, Gabriel Paiva da Silva Lima, Marc S. Sabatine, Unknown

Open source

DOI
10.1161/circulationaha.126.082436
Published
2026-08-31
Container
Circulation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/circulationaha.126.082436,
  title = {Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial},
  author = {Robert P. Giugliano and Erin A. Bohula and Andrea Bellavia and Gaetano M. De Ferrari and Lawrence A. Leiter and Jose C. Nicolau and Ajay K. Bhatia and Sabina A. Murphy and Lyrica Liu and Huei Wang and Vladimir Blaha and Andrejs Erglis and Jorge Ferreira and Assen Goudev and Henrik K. Jensen and Robert Gabor Kiss and Gilles Montalescot and Alexandr Parkhomenko and Naveed Sattar and Peter Sinnaeve and Rimvydas Slapikas and Gabriel Paiva da Silva Lima and Marc S. Sabatine and Unknown},
  year = {2026},
  journal = {Circulation},
  doi = {10.1161/circulationaha.126.082436},
  url = {https://doi.org/10.1161/circulationaha.126.082436}
}

RIS

TY  - JOUR
TI  - Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial
AU  - Robert P. Giugliano
AU  - Erin A. Bohula
AU  - Andrea Bellavia
AU  - Gaetano M. De Ferrari
AU  - Lawrence A. Leiter
AU  - Jose C. Nicolau
AU  - Ajay K. Bhatia
AU  - Sabina A. Murphy
AU  - Lyrica Liu
AU  - Huei Wang
AU  - Vladimir Blaha
AU  - Andrejs Erglis
AU  - Jorge Ferreira
AU  - Assen Goudev
AU  - Henrik K. Jensen
AU  - Robert Gabor Kiss
AU  - Gilles Montalescot
AU  - Alexandr Parkhomenko
AU  - Naveed Sattar
AU  - Peter Sinnaeve
AU  - Rimvydas Slapikas
AU  - Gabriel Paiva da Silva Lima
AU  - Marc S. Sabatine
AU  - Unknown
PY  - 2026
JO  - Circulation
DO  - 10.1161/circulationaha.126.082436
UR  - https://doi.org/10.1161/circulationaha.126.082436
ER  - 

APA

Giugliano, R. P., Bohula, E. A., Bellavia, A., Ferrari, G. M. D., Leiter, L. A., Nicolau, J. C., Bhatia, A. K., Murphy, S. A., Liu, L., Wang, H., Blaha, V., Erglis, A., Ferreira, J., Goudev, A., Jensen, H. K., Kiss, R. G., Montalescot, G., Parkhomenko, A., Sattar, N., Sinnaeve, P., Slapikas, R., Lima, G. P. D. S., Sabatine, M. S., & Unknown (2026). Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial. Circulation. https://doi.org/10.1161/circulationaha.126.082436

Source records